Covestor
PTGX icon

Covestor’s Protagonist Therapeutics PTGX Stock Holding History

Covestor’s Portfolio PTGX Stock Details PTGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-1,528
Closed -$188K – 2733
2026
Q2 		$188K Buy
1,528
+653
+75% +$68.2K 0.11% 140
2026
Q1 		$92K Sell
875
-562
-39% -$49.8K 0.06% 332
2025
Q4 		$125K Buy
1,437
+447
+45% +$36.6K 0.07% 445
2025
Q3 		$66K Sell
990
-755
-43% -$42.9K 0.04% 778
2025
Q2 		$97K Sell
1,745
-342
-16% -$16.4K 0.06% 573
2025
Q1 		$101K Buy
2,087
+444
+27% +$18.6K 0.07% 485
2024
Q4 		$63K Buy
1,643
+1,612
+5,200% +$70.3K 0.04% 768
2024
Q3 		$1K Buy
31
+23
+288% +$929 ﹤0.01% 2075
2024
Q2 		$0 Buy
8
+4
+100% +$117 ﹤0.01% 2645
2024
Q1 		$0 Sell
4
-1
-20% -$27 ﹤0.01% 2631
2023
Q4 		$0 Hold
5
– – ﹤0.01% 2590
2023
Q3 		$0 Sell
5
-1
-17% -$19 ﹤0.01% 2586
2023
Q2 		$0 Sell
6
-4
-40% -$100 ﹤0.01% 2535
2023
Q1 		$0 Hold
10
– – ﹤0.01% 2461
2022
Q4 		$0 Buy
+10
New +$84 ﹤0.01% 2487
2022
Q3 		– Sell
-9
Closed – – 2457
2022
Q2 		$0 Sell
9
-2
-18% -$24 ﹤0.01% 2266
2022
Q1 		$0 Sell
11
-3
-21% -$85 ﹤0.01% 2372
2021
Q4 		$0 Buy
+14
New +$443 ﹤0.01% 2264

Other funds holding PTGX

UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Johnson & Johnson
Johnson & Johnson New Brunswick, New Jersey $762M AUM 69.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 20.64% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $229B AUM 33.35% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $109B AUM 51.53% 1-Year Est. Return

Covestor's PTGX Position: Q3 2026 in Review

Covestor sold out of Protagonist Therapeutics (PTGX) in Q3 2026, closing a stake of 1,528 shares — an estimated $188K sold.

Covestor first reported a position in PTGX in Q4 2021 and held it in 18 quarters. The position peaked at $188K in Q2 2026. 252 funds tracked by Wall St. Rank hold PTGX as of Q3 2026.

  • Covestor reported no remaining Protagonist Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Covestor sold 1,528 Protagonist Therapeutics shares in Q3 2026, an estimated $188K.
  • Covestor first reported a position in Protagonist Therapeutics in Q4 2021 and held it in 18 quarters.
  • Covestor's Protagonist Therapeutics position peaked at $188K in Q2 2026.
  • 252 funds tracked by Wall St. Rank held Protagonist Therapeutics as of Q3 2026.

Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.